Skip to main content
Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.990
-0.170 (-4.09%)
At close: Feb 27, 2026, 4:00 PM EST
4.070
+0.080 (2.01%)
After-hours: Feb 27, 2026, 7:36 PM EST

Alvotech Revenue

Alvotech had revenue of $113.86M in the quarter ending September 30, 2025, with 10.56% growth. This brings the company's revenue in the last twelve months to $573.35M, up 45.55% year-over-year. In the year 2024, Alvotech had annual revenue of $491.98M with 426.84% growth.

Revenue (ttm)
$573.35M
Revenue Growth
+45.55%
P/S Ratio
2.18
Revenue / Employee
$566,551
Employees
1,012
Market Cap
1.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024491.98M398.60M426.84%
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 202069.45M-13.23M-16.00%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
Evotec SE 887.40M
BioCryst Pharmaceuticals 874.84M
Tilray Brands 837.32M
ANI Pharmaceuticals 826.88M
Collegium Pharmaceutical 780.57M
Amphastar Pharmaceuticals 723.31M
Pacira BioSciences 716.79M
Revenue Rankings

ALVO News

More News